EUVIMEDEUVIMED entdecken
Open Access

TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia

Yajuan Cui, Hongyan Tong, Xin Du, Bing Li, Robert Peter Gale, Tiejun Qin, Jinqin Liu, Zefeng Xu, Yue Zhang, Gang Huang, Jie Jin, Liwei Fang und 5 weitere

Stem Cell Investigation · 26.09.2016 · 3 · 50-50

DOI: 10.21037/sci.2016.09.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Investigation, online erschienen am 26.09.2016. Verfasst von Yajuan Cui und 16 weiteren Autor:innen. Beteiligte Einrichtung: MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin …. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ASXL1 mutationsTET2 mutationschronic myelomonocytic leukemia (CMML)prognosis

Autor:innen und Institutionen

  • MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China;; State Key Laboratory of Experimental Hematology, Insti…
  • Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310000, China.
  • Department of Hematology, Guangdong General Hospital, Guangzhou 510010, China.
  • Hematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.
  • MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
  • State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Zitieren

APA

Cui, Y., Tong, H., Du, X., Li, B., Gale, R. P., Qin, T., Liu, J., Xu, Z., Zhang, Y., Huang, G., Jin, J., Fang, L., Zhang, H., Pan, L., Hu, N., Qu, S., & Xiao, Z. (2016). TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. Stem Cell Investigation, 3, 50-50. https://doi.org/10.21037/sci.2016.09.04

Vancouver

Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, et al. TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. Stem Cell Investigation. 2016;3:50-50. doi:10.21037/sci.2016.09.04

BibTeX
@article{Cui2016,
  author = {Cui, Yajuan and Tong, Hongyan and Du, Xin and Li, Bing and Gale, Robert Peter and Qin, Tiejun and Liu, Jinqin and Xu, Zefeng and Zhang, Yue and Huang, Gang and Jin, Jie and Fang, Liwei and Zhang, Hongli and Pan, Lijuan and Hu, Naibo and Qu, Shiqiang and Xiao, Zhijian},
  title = {TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia},
  journal = {Stem Cell Investigation},
  year = {2016},
  volume = {3},
  pages = {50--50},
  doi = {10.21037/sci.2016.09.04}
}
Kostenlos starten →